Validity of the Spanish version of the Personal and Social Performance scale in schizophrenia

Schizophrenia Research

Volumn 112, Issue 1-3, 2009, Pages 181-186

  Apiquian, Rogelio ^a,d   Elena Ulloa, Rosa ^b   Herrera Estrella, Miguel ^c   Moreno Gómez, Araceli ^c   Erosa, Sandra ^d   Contreras, Veronica ^a   Nicolini, Humberto ^d  

^a Las Americas University   (Mexico)

^b Hospital Psiquiatrico Infantil Dr Juan N Navarro   (Mexico)

^c HOSPITAL PSIQUIÁTRICO FRAY BERNARDINO ÁLVAREZ   (Mexico)

^d Carracci Medical Group   (Mexico)

Author keywords

PSP; Reliability; Scale; Schizophrenia; Social functioning; Spanish version; Validity

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DISCRIMINANT VALIDITY; DISEASE DURATION; DISEASE SEVERITY; EDUCATION; FEMALE; HOSPITAL PATIENT; HUMAN; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PERSONAL AND SOCIAL PERFORMANCE SCALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SOCIAL INTERACTION; TREATMENT DURATION; UNEMPLOYMENT;

ADOLESCENT; ADULT; AGED; CROSS-CULTURAL COMPARISON; FEMALE; HUMANS; MALE; MIDDLE AGED; PERSONALITY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; STATISTICS AS TOPIC; TRANSLATING; YOUNG ADULT;

EID: 67349189933     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.03.028     Document Type: Article

References (30)

1. o ed. (2000), JGH, Mexico
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (1994), American Psychiatric Association, Washington DC
3. Birchwood M., Smith J., Cochrane R., Wetton S., and Copestake S. The social functioning scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br. J. Psychiatry 157 (1990) 853-859
4. Burns T. Evolution of outcome measures in schizophrenia. Br. J. Psychiatry Suppl 50 (2007) s1-s6
5. Burns T., and Patrick D. Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatr. Scand. 116 (2007) 403-418
6. Canuso C.M., Youssef E.A., Bossie C.A., Turkoz I., Schreiner A., and Simpson G.M. Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone. Int. Clin. Psychopharmacol. 23 (2008) 209-215
7. Davidson M., Emsley R., Kramer M., et al. Efficacy, safety and early response of paliperidone extended-release tablets (paliperidone ER): results of a 6-week, randomized, placebo-controlled study. Schizophr. Res. 93 (2007) 117-130
8. Endicott J., Spitzer R.L., Fleiss J.L., and Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry 33 (1976) 766-771
9. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinician Version (1996), American Psychiatric Press, Washington, DC
10. Fresan A., De la Fuente-Sandoval C., Loyzaga C., et al. A forced five-dimensional factor analysis and concurrent validity of the positive and negative syndrome scale in Mexican schizophrenic patients. Schizophr. Res. 72 (2005) 123-129
11. Gagnon D., Nasrallah H., and Morosini P. Personal and Social Performance scale: measuring functional improvement in outpatients with stable schizophrenia. Poster No. NR348 Presented at APA 2006, Canada (2006)
12. Green M.F., Kern R.S., Braff D.L., and Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 26 (2000) 119-136
13. Green M.F., Kern R.S., and Heaton R.K. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr. Res. 72 (2004) 41-51
14. Green M.F., Nuechterlein K.H., Kern R.S., et al. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Am. J. Psychiatry 165 (2008) 221-228
15. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised (1976), US Department of Health, Education and Welfare, National Institute of Mental Health, Rockville, Md
16. Juckel G., Schaub D., Fuchs N., et al. Validation of the Personal and Social Performance (PSP) scale in a German sample of acutely ill patients with schizophrenia. Schizophr. Res. 104 (2008) 287-293
17. Keefe R.S. Cognitive deficits in patients with schizophrenia: effects and treatment. J. Clin. Psychiatry 68 Suppl 14 (2007) 8-13
18. Keefe R.S., Silva S.G., Perkins D.O., and Lieberman J.A. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr. Bull. 25 (1999) 201-222
19. Marder S.R., Kramer M., Ford L., et al. Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study. Biol. Psychiatry 62 (2007) 1363-1370
20. Marshall M., Lewis S., Lockwood A., Drake R., Jones P., and Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch. Gen. Psychiatry 62 (2005) 975-983
21. Meltzer H.Y., Bobo W.V., Nuamah I.F., et al. Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies. J. Clin. Psychiatry 69 (2008) 817-829
22. Milev P., Ho B.C., Arndt S., and Andreasen N.C. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am. J. Psychiatry 162 (2005) 495-506
23. Morosini P.L., Magliano L., Brambilla L., Ugolini S., and Pioli R. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr. Scand. 101 (2000) 323-329
24. Munroe-Blum H., Collins E., McCleary L., and Nuttall S. The social dysfunction index (SDI) for patients with schizophrenia and related disorders. Schizophr. Res. 20 (1996) 211-219
25. Patrick D., Morosini P., and Rothman M. Personal and Social Performance Scale: reliability, validity and ability to detect change in patients with acute schizophrenia. Poster No. NR416 Presented at APA 2006, Canada (2006)
26. Priebe S. Social outcomes in schizophrenia. Br. J. Psychiatry Suppl 50 (2007) s15-s20
27. Priebe S., Roeder-Wanner U.U., and Kaiser W. Quality of life in first-admitted schizophrenia patients: a follow-up study. Psychol. Med. 30 (2000) 225-230
28. Schooler N.R., Hogarty G.E., and Weissman M.M. Social adjustment scale II. In: Hargreaves W.P., Atkinson C.C., and Sorenson J.E. (Eds). Resource Materials for Community Health Program Evaluations. 2nd ed. Publication ADM. 79-328: Rockville, MD: US Department of Health, Education, and Welfare (1979) 290-302
29. Valencia M., Rojas E., Gonzalez C., Ramos L., and Villatoro J. Evaluation of social functioning in patients at a health center. Salud Publica Mex. 31 (1989) 674-687
30. Weissman M.M., and Bothwell S. Assessment of social adjustment by patient self-report. Arch. Gen. Psychiatry 33 (1976) 1111-1115